Linda Geddes

Linda Geddes is a science journalist who writes for The Guardian. She covers topics such as health, environment, and technology. She has a degree in biology from the University of Cambridge and a master's in journalism from City University London.

Biography:  https://www.theguardian.com/profile/linda-geddes

41%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a poor reputation for journalistic standards and is not considered a reliable news source.

Bias

10%

Examples:

  • The article seems to have a positive bias towards the new antibiotic and its potential benefits. It does not provide any balanced or critical view on the topic.

Conflicts of Interest

50%

Examples:

  • The article does not appear to have any clear conflicts of interest, but it may be biased towards the pharmaceutical industry that funded the research on Zosurabalpin.

Contradictions

50%

Examples:

  • There are several contradictions in the article regarding the effectiveness of Zosurabalpin against drug-resistant bacteria. The quotes from Dr Lobritz and Dr Edwards suggest that there is no evidence or context for their claims.

Deceptions

50%

Examples:

  • The article contains some deceptive practices such as using vague or misleading statements from experts without providing any evidence or context. It also does not provide any information on the side effects, costs, or limitations of Zosurabalpin.

Recent Articles

Smartphone App Detects Early Signs of Frontotemporal Dementia in High-Risk Individuals with Accuracy

Smartphone App Detects Early Signs of Frontotemporal Dementia in High-Risk Individuals with Accuracy

Broke On: Wednesday, 03 April 2024 A smartphone app developed by collaborating with Datacubed Health can accurately detect early signs of frontotemporal dementia in individuals at high genetic risk for developing it, even those who have not shown any obvious symptoms yet. The app records people's speech while they engage with several cognitive tests including executive functioning assessments and is found to be as sensitive as medical evaluations performed in clinics.
New Antibiotic Offers Hope Against Hospital Superbugs

New Antibiotic Offers Hope Against Hospital Superbugs

Broke On: Wednesday, 03 January 2024 Zosurabalpin is a new class of antibiotics that has been discovered after screening about 45,000 small molecules with potential antibiotic properties. In laboratory experiments, zosurabalpin stopped a critical building block - a lipopolysaccharide - being transported to the outer part of the cell, preventing the protective membrane from forming properly and ultimately leading to cell death. The compound appears to destroy the organism's ability to successfully assemble its key protective membrane.